Acción 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Acciones

002864

CNE1000032C9

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 17/05/2024 		Varia. Cinco días. Varia. 1 de enero.
29,57 CNY -1,60 % Gráfico intradía de Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -1,27 % -23,17 %
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd informa de los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.
Panlong Pharmaceutical Plans 20 Million Yuan Share Buyback
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announces an Equity Buyback for CNY 20 million worth of its shares.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd authorizes a Buyback Plan.
Panlong Pharmaceutical Gets Sanitary License
Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Panlong Pharma Completes Registration of New Medical Clinic
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Approves Cash Dividend for 2022, Payable on May 31, 2023
Chinese Shares Retreat; Panlong Pharma Falls 7% on 302 Million Yuan Share Sale
Shaanxi Panlong Pharma Selling 302 Million Yuan Shares to Fund New Projects
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Proposes Final Cash Dividend for 2022
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Panlong Pharma Gets US Patent for Coronavirus Protease Inhibitor
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 002864
  4. Noticias Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
  5. Otros idiomas